The FDA highlights increased toxicity risks in patients with DPD deficiency when using Xeloda and 5-FU, urging genetic testing before treatment. DPD deficiency leads to severe side effects from ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Administration of 5-FU bolus did not affect survival for ...
The plan-act-study-do QI methodology was used to identify potential hazardous drug exposures and implement procedures to minimize those risks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback